1 November 2010 in Genetic Vaccines and Therapy
Background: Immunization of mice with tumor homogenate after combined treatment with cyclophosphamide (CP) and double-stranded DNA (dsDNA) preparation is effective at inhibition of growth of tumor challenged after the treatment. It was assumed that this inhibition might be due to activation of the antigen-presenting cells. The purpose was to develop improved antitumor strategy using mice. We studied the combined action of cytostatics doxorubicin (Dox) plus CP with subsequent dsDNA preparation on tumor growth.Methods: Three-month old CBA/Lac mice were used in the experiments. Mice were injected with CP and human dsDNA preparation. The percentage of mature dendritic cells (DCs) was estimated by staining of mononuclear cells isolated from spleen and bone marrow 3, 6, and 9 days later with monoclonal antibodies CD34, CD80, and CD86. In the next set of experiments, mice were given intramuscularly injections of 1-3 × 105tumor cells. Four days later, they were injected intravenously with 6-6.7 mg/kg Dox and intraperitoneally with 100-200 mg/kg CP; 200 mkg human DNA was injected intraperitoneally after CP administration. Differences in tumor size between groups were analyzed for statistical significance by Student's t-test. The MTT-test was done to determine the cytotoxic index of mouse leucocytes from treated groups.Results: The conducted experiments showed that combined treatment with CP and dsDNA preparation produce an increase in the total amount of mature DCsin vivo. Treatment of tumor bearers with preparation of fragmented dsDNA on the background of pretreatment with Dox plus CP demonstrated a strong suppression of tumor growth in two models. RLS, a weakly immunogenic, resistant to alkalyting cytostatics tumor, grew 3.4-fold slower when compared with the control (p < 0.001). In experiment with Krebs-2 tumor, only 2 of the 10 mice in the Dox+CP+DNA group had a palpable tumor on day 16. The cytotoxic index of leucocytes was 86.5% in the Dox+CP+DNA group, but it was 0% in the Dox+CP group.Conclusions: Thus, the set of experiments we performed showed that exogenous dsDNA, when administered on the background of pretreatment with Dox plus CP, has an antitumor effect possibly due to DC activation.
1 October 2007 in Optics and Spectroscopy
A new model of the action of low-intensity laser radiation (LILR) on biological objects on the cellular level is proposed. The model implies that, because the laser radiation is coherent, the...
1 January 2006 in Doklady Biological Sciences
1 March 2003 in Bulletin of Experimental Biology and Medicine
1 April 2024 in The EYE GLAZ
Introduction. Brown’s syndrome (BS) is a rare type of unconcomitant strabismus, which is often interpreted by practicing ophthalmologists as a paralytic form. The difficulty of diagnosis is due to the similarity of clinical manifestations with a number of other oculomotor disorders. This leads to a late, and most importantly, tactically incorrect choice of surgical treatment method. Purpose: Development of an algorithms for differential diagnosis and surgical treatment of Brown syndrome. Materials and methods. The authors analyzed the experience of diagnosing and treating 99 patients with Brown’s syndrome. The follow-up period was 13 years, from May 2010 to May 2023. Among the examined patients, 35 (35 %) were male and 64 (65 %) were female. The median age was 7.19 ± 0.87 years, the oldest at the time of the study was 45 years old, and the youngest was 1.5 years old. All patients underwent standard ophthalmologic and strabismal examinations. In patients of verbal age, the nature of vision was examined (Worth test, Bagolini test, double Maddox test). All operated patients underwent a cyclotorsion test intraoperatively under general anesthesia to confirm the diagnosis and choose a surgical method. Surgical treatment was carried out in 60 cases of unilateral and 5 cases of bilateral BS (a total of 65 patients aged 2 to 45 years; 69 eyes). Tenotomy and tenectomy of the superior oblique muscle (ECM) were performed in 53 cases, prolongation and recession with prolongation of the ECM in 16 cases. Results. Clinical signs have been systematized, algorithms for differential diagnosis and surgical treatment have been developed, which make it possible to timely identify Brown’s syndrome and carry out stage-by-stage pathogenetically based surgical treatment. The results are presented in the form of sequential action schemes (algorithms) that will help practitioners in making a diagnosis and determining the correct tactics of surgical treatment. Conclusions. Brown syndrome has characteristic differential features and requires staged surgical treatment. Developed algorithms to obtain high functional and cosmetic results.